Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Instruments Revenue	3.18B	2.83B
Instruments Revenue Growth	12.31%	11.84%
Endoscopy Revenue	3.81B	3.39B
Endoscopy Revenue Growth	12.33%	10.46%
Medical Revenue	4.20B	3.85B
Medical Revenue Growth	9.14%	11.36%
Neurovascular Revenue	1.97B	1.31B
Neurovascular Revenue Growth	50.57%	6.61%
Neuro Cranial Revenue	2.49B	2.14B
Neuro Cranial Revenue Growth	16.34%	13.86%
MedSurg & Neurotechnology Revenue	15.65B	13.52B
MedSurg & Neurotechnology Revenue Growth	15.75%	11.14%
Knees Revenue	2.66B	2.45B
Knees Revenue Growth	8.54%	7.66%
Hips Revenue	1.87B	1.70B
Hips Revenue Growth	9.45%	10.36%
Trauma and Extremities Revenue	3.95B	3.51B
Trauma and Extremities Revenue Growth	12.57%	11.44%
Spinal Implants Revenue	185.00M	707.00M
Spinal Implants Revenue Growth	-73.83%	-0.84%
Other Orthopaedics Revenue	815.00M	712.00M
Other Orthopaedics Revenue Growth	14.47%	8.21%
Orthopaedics Revenue	9.47B	9.08B
Orthopaedics Revenue Growth	4.32%	8.90%
Revenue (Total)	25.12B	22.60B
Revenue (Total) Growth	11.16%	10.23%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	19.01B	16.94B
United States Revenue Growth	12.18%	11.05%
International Revenue	6.11B	5.65B
International Revenue Growth	8.10%	7.84%
Revenue (Total)	25.12B	22.60B
Revenue (Total) Growth	11.16%	10.23%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
MedSurg & Neurotechnology Operating Income	4.67B	4.00B
MedSurg & Neurotechnology Operating Income Growth	16.68%	15.39%
Orthopaedics Operating Income	2.82B	2.59B
Orthopaedics Operating Income Growth	8.84%	14.39%
Operating Income (Other)	-2.60B	-2.91B
Operating Income (Total)	4.89B	3.69B
Operating Income (Total) Growth	32.53%	-5.12%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Organic Net Sales Growth	10.30%	10.20%

Updated Dec 31, 2025. Data Source: Fiscal.ai.